• About
• Links
• Contact
• Sitemap

Sitemap > Clinical Trials > Infectious Diseases

• PROcalcitonin Reduce Antibiotic Treatments in Acute-Ill Patients (PRORATA)
• Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults
• The Influence of Lopinavir/Ritonavir on Gemfibrozil Pharmacokinetics in Healthy Volunteers
• Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children.
• Vicriviroc To Be Studied In Combination With An Optimized Antiretroviral Regimen Offered To HIV-Treatment Experienced Subjects (Study P04889)
• Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above
• A Phase I/IIa Multicenter Dose-Escalation Study of Subcutaneous Intermittent Interleukin-7 CYT107 in Chronically HIV-Infected Patients With CD4 T-Lymphocyte Counts Between 101-400 Cells/mm(3) and Plasma HIV RNA Less Than 1000 Copies/ml After at Least 12 Months of HAART
• Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia
• Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)
• IMPROVE Study(The Individualized Management With PEGASYS and Ribavirin Offering Viral Eradication): A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Non-Genotype 2/3.
• Efavirenz-Based Versus Nevirapine-Based Antiretroviral Therapy Among HIV-Infected Patients Receiving Rifampin
• Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine 580299 in Healthy Females 10 - 25 Years of Age.
• Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients
• A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
• Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines
• Efficacy, Safety, Reactogenicity & Immunogenicity of the Human Rotavirus Vaccine (HRV) 444563 in Japanese Infants
• Safety and Effectiveness of Raltegravir (MK-0518) in Treatment-Experienced, HIV Infected Children and Adolescents
• A Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV Vaccine in Healthy Females Aged 15-25 Years.
• A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
• Expanded Characterization of Immune Response to Merck Adenovirus 5 Gag/Pol/Nef Vaccine Given to HIV Uninfected Adults
• Safety Study of Nifurtimox for Relapsed or Refractory Neuroblastoma
• Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults
• AMICI Study: A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients.
• Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age
• Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI
• Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients
• A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy
• Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age
• A Phase I Open-Label Study of the Safety and Immunogenicity of a Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for the Influenza Virus H5 Hemagglutinin Protein Administered Intradermally in Healthy Adults
• A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B.
• A Study to Evaluate Efficacy and Safety of Four Posaconazole Regimens With Placebo and Terbinafine in the Treatment of Toenail Onychomycosis (Study P05082)
• Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children
• Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine With Influenza Vaccine in Adults
• Immunogenicity and Safety of GSK Biologicals
• Month 30 & 42 Extension Studies of CRD-004 Primary Study
• Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem
• Pharmacokinetic and Safety Study of HYLENEX Recombinant-Augmented Subcutaneous Ceftriaxone Administration
• Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB co-Infected Patients (ANRS 12146)
• MDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary Tuberculosis
• Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C
• A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus
• Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A
• A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Negative Chronic Hepatitis Due to Hepatitis B Virus
• Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus
• Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects
• Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts
• A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets.
• Intermittent Use of Aerosolized Ribavirin for Treatment of RSV
• Evaluate Safety and Immunogenicity of a Pandemic Influenza Vaccine (GSK1119711A) in Children
• Study Of RV-39 In Patients Who Also Have Asthma
• Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus
• Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis
• TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)
• Safety and Efficacy Study of KP-1461 to Treat ART-Experienced HIV+ Patients
• Safety Study of Oral BTA9881 to Treat RSV Infection
• Evaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed Adults.
• A Study to Compare Tenofovir Versus Tenofovir Plus Emtricitabine for the Treatment of Chronic Hepatitis B
• Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexa Versus Individual Administration of Each Vaccine
• Safety and Efficacy Study of Plasmodium Falciparum LSA-3 Malaria Vaccine
• Study of Telaprevir in Subjects With Hepatic Impairment
• Antidepressant Medication and Cognitive Behavioral Therapy to Help HIV Infected Adults With Depression to Adhere to Antiretroviral Therapy
• A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis
• Autologous Dendritic Cell Vaccine in HIV1 Infection
• Tinidazole for Recurrent Bacterial Vaginosis: A Pilot Study
• Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults
• Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*
• TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously
• Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
• Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania
• Phase I Study to Investigate the Safety and Efficacy of HBV DNA Vaccine
• Proof of Concept Study to Determine Efficacy and Safety of SCV-07 in Patients With Chronic Relapsed Hepatitis C
• DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis
• Eltrombopag to Initiate and Maintain Interferon Antiviral Treatment to Subjects With Hepatitis C Related Liver Disease
• A Study of HCV Polymerase Inhibitor Pro-Drug in Combination With PEGASYS® Plus COPEGUS Compared With PEGASYS® Plus COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection.
• Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients
• A Phase I/IIa Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of an H5N1 Virus-Like Particle (VLP) Influenza Vaccine (Recombinant)
• Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment
• Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency
• Broad Spectrum HPV (Human Papillomavirus) Vaccine (V505) in 16 to 26 Year Old Women
• Integrase Inhibitor (MK-0518) Viral Decay
• Phase II Artesunate Study in Severe Malaria
• A Study of the PK, Safety and Antiviral Activity of A-831 in HCV Carriers
• Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405)
• Double-Blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20mg in Sore Throat
• Standard Antiretroviral Versus Multi-Class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01)
• Single Dose Escalating Study of DAS181 in Adults
• Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults.
• VX-950-TiDP24-C208: An Open-Label Study of Telaprevir Administered Every 12 or Every 8 Hours in Combination With Standard Treatment in Treatment naïve Patients With Chronic Genotype 1 Hepatitis C
• Epoetin Alfa for HIV-Associated Neuropathy Trial
• Statins for the Early Treatment of Sepsis
• Switching From PI to RALtegravir in HIV Stable Patients
• Evaluating the Effect of Switching Enfuvurtide to MK-0518 (Raltegravir) in HIV Infected Subjects
• Evaluate Safety & Immunogenicity of GSK Bio CMV Vaccine in CMV-Seronegative Healthy Male Adult Subjects
• Eltrombopag to Initiate and Maintain Interferon Antiviral Treatment to Benefit Subjects With Hepatitis C Liver Disease
• Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients
• Pilot Study of Patients Chronic Hepatitis C in co-Infected HIV Patients Relapsers After Previous Therapies
• Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-Resistant Chronic Hepatitis B
• Double Protease Inhibitor to Darunavir Switch Study
• Non-Inferiority of Various GSK Bios Influenza Vaccine Presentations in Adults Aged 65 Years and Over.
• Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR
• A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART)
• Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg
• Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Wks of Age
• Effectiveness, Safety and Immunogenicity of GSK Biologicals HPV Vaccine GSK580299 Administered in Healthy Adolescents.
• Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™
• A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults
• A Rollover Study for Subjects Participating in the Control Arm of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Whose Plasma HCV RNA Levels Did Not Respond to Therepy
• PegIntron Treatment of Chronic Hepatitis B e Antigen-Positive Patients (Study P05170)
• Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
• Interferon-Gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-Responders
• GSK706769 A First Time in Human Study For Males and Females
• Influenza Vaccine GSK1247446A With Formulations
• Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bios HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs
• Effects of the RI-001 Device on Hepatic Function in Patients With Chronic Hepatitis C Virus Infection
• Efficacy Study of Substitution of Darunavir /Ritonavir (DRV/r) for Dual-Boosted Protease Inhibitors
• Revaccination With Influenza Vaccine GSK1247446A
• A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS® (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.
• A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
• Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV
• Effect of Taurolidin on Prevention of Bloodstream Infection
• Study of a Potential Preventive Vaccine Against HIV in Healthy Volunteers
• Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America
• Tolerability and Immunogenicity of RUTI Antituberculous Vaccine in Healthy Volunteers, Phase I Clinical Trial
• Study Evaluating the Safety, Tolerability and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC)
• The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s)
• Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy Adults
• A Single Ascending Dose Study of BMS-790052 in HCV Infected Subjects
• ZOSTAVAX(TM) in Patients on Chronic/Maintenance Corticosteroids
• A Phase II Clinical Study of PDC-748 in Patients With Acute Cough
• KIVEXA Vs Truvada, Both Administered With Efavirenz, In ART-Naive Subjects.
• A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections. (P05090)
• ZOSTAVAX(TM) Safety Study in Subjects 60 Years of Age or Older
• Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875)
• Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects
• A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL
• Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057)
• Montelukast as Prophylaxis for Upper Respiratory Tract Infections in Children: a Randomised, Double-Blind, Placebo-Controlled Study
• Immunogenicity and Safety of GlaxoSmithKline Biologicals HPV Vaccine 580299 in Healthy Females 15 - 25 Years of Age
• Comparative Study of Immunogenicity and Safety of Flu-ID Vaccine Versus Flu-IM Vaccine
• Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression
• Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.
• Efficacy Study of Oseltamivir (Tamiflu) for Treating and Preventing Influenza
• Phase IV Clinical Trial of an Influenza Split Vaccine Anflu
• Evaluation of Safety and Pharmacokinetics of Single Doses of VBY-376 in Healthy Adults
• Switching Study From Lamivudine to Clevudine Versus Continued Lamivudine in the Chronic Hepatitis B Patients
• Long-Term Study With Clevudine
• A Single Ascending Dose Study of BMS-650032 in HCV Infected Subjects
• Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone Vaccine
• VX-950-TiDP24-C209: A Phase 2a Partially Blinded Clinical Study to Evaluate the Viral Kinetics and Safety of Telaprevir in Patients With Genotype 2 or 3 Infection.
• Immunogenicity and Safety of a 1-Dose Regimen of a Zoster Vaccine Versus Different 2-Dose Regimens in Subjects ≥ 70 Years
• TMC435350-TiDP16-C201 - OPERA 1: A Study of the Hepatitis C Virus (HCV) Protease Inhibitor TMC435350 or Placebo Administered With or Without the Standard of Care in Treatment naïve and Treatment Experienced Patients Infected With Genotype 1 Hepatitis C Virus.
• Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel
• Comparison of Three Drug Combinations for Intermittent Treatment of Malaria in Chidren
• VERVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients
• Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery
• Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine
• Raltegravir Kaletra Pharmacokinetics
• Efficacy and Safety of ASF1057 in the Treatment of Seborrhoeic Dermatitis
• Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection
• Pathogen Identification of Bacterial Pneumonia Via DNA Detection
• Study of Two Formulations of GSK Biologicals' Varicella Vaccine
• A Post Marking Study to Evaluate the Safety of FluMist in Children
• Study of CTS-1027 in Hepatitis C Patients
• Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
• Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive Patients
• Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir)
• Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Healthy Vietnamese Women According to a 0, 1, 6 Month Schedule
• A Pilot Study of Daptomycin for Antimicrobial Prophylaxis (Daptomycin)
• Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA) (DAYANA)
• Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis (CHASE)
• Study Evaluating the Safety, Tolerability and Immunogenicity of 13vPnC as a 2-Dose Regimen or With 23vPS
• Evaluation of Clinical Efficacy and Immunologic Response After IL-2 Therapy in HCV-Related Vasculitis Patients
• Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine in Healthy Japanese Infants
• Evaluation of Safety and Immunogenicity of co-Administering HPV Vaccine With Another Vaccine in Healthy Female Subjects.
• Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age
• A Phase I, Randomized, Double-Blind, Single-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-557
• A Multi-Centre, Double-Blinded, Randomized, Placebo-Controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome
• A Phase II Study of AL-15469A /AL-38905 for Treatment of Marginal Corneal Infiltrates
• VX-950-TiDP24-C210: A Study to Assess the Activity of Telaprevir on Hepatitis C Virus in Treatment naïve Patients Who Are Chronically Infected With Hepatitis C Genotype 4 Infection
• Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine (VEE C-84) as a Booster to VEE TC-83 (VEE C-84)
• Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis
• Safety and Immunogenicity Study of Rift Valley Fever Vaccine (RVF)
• Safety and Immunogenicity of GlaxoSmithKline Biologicals HPV Vaccine 580299 in HIV Infected Females
• Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants
• Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B
• Study of Safety, Tolerability, and Anti-Viral Effect of Locteron Compared to PEG-Intron in Patients With Chronic Hepatitis C (PLUS)
• Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
• Safety, Pharmacokinetics, and Pharmacodynamics of SD-101 in Healthy Normal Males
• Immunogenicity and Safety of a Candidate Tuberculosis (TB) Vaccine Given to Healthy Adults in a TB-Endemic Region
• A Study of an Antibiotic Implant in General Surgical Subjects at Higher Risk for Surgical Wound Infection
• Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock
• A Phase I Study to Evaluate the Safety and Immunogenicity of an Ebola DNA Plasmid Vaccine, VRC-EBODNA023-00-VP, and a Marburg DNA Plasmid Vaccine, VRC-MARDNA025-00-VP, in Healthy Adults
• Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in Sepsis
• FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy
• Clinical Pilot, Open, Comparative and Randomised Trial to Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antirretroviral Treatment Simplification Strategy (DRV900100QD)
• Safety and Efficacy of CJ-50300 in Healthy Volunteers
• Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours
• A Phase I/IIa Study of the Safety, Immunogenicity and Parasite Growth Inhibitory Activity of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria
• Controlled Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)
• Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B
• Safety of and Immune Response to an Adenoviral HIV-1 Vaccine in Healthy Adults
• Pharmacokinetics of Low Dose Ritonavir
• Sulforaphane as an Antagonist to Human PXR-Mediated Drug-Drug Interactions
• Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and Above
• Safety and Immunogenicity Study of GSK Biologicals Tuberculosis Vaccines (692342) to Healthy Adults
• Naïve HIV POC Monotherapy Trial
• Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients
• Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children
• Lopinavir/Ritonavir Monotherapy in Children
• T.E.A. Study Three Days Ertapenem vs Three Days Ampicillin- Sulbactam (TEA)
• Efficacy and Safety of Pegylated Interferon Plus Ribavirin Combination Therapy in Treating Older Patients With Chronic Hepatitis C
• Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Toddlers
• A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 HCV
• A Study of Combination Therapy With PEGASYS (Peginterferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response.
• An Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visceral Leishmaniasis
• Moxifloxacin Plus Metronidazole Versus Piperacillin/Tazobactam for the Treatment of Patients With Intra-Abdominal Abscesses (MEMO)
• Genetic Predictors of Variability in the Drug-Drug Interaction Between Darunavir/Ritonavir and Pravastatin
• Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA
• Raltegravir Substitution for Enfuvirtide in Patients Suffering From Injection Site Reactions (ISRs): The Raleve Pilot Study
• Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis
• Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide (Temo/Azac)
• Raltegravir Intensification in HIV-Infected Patients
• Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis
• A Phase 1 Study of MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis C
• Phase I Safety Study of a Recombinant MVA HIV Multiantigen Vaccine in HIV-Infected Subjects
• Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons
• A Phase IV, Randomised Study to Evaluate the Immune Response of UK Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life (Sched2)
• Safety and Efficacy Pilot Study of AzaSite® in Subjects With Blepharitis
• GSK1349572 Repeat Dose Escalation and Relative Bioavailability Study
• Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study)
• A Study of Invirase (Saquinavir)/Ritonavir in HIV-Infected Infants and Children.
• Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection
• A Single-Arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without Add-on Tenofovir in Adults With HBeAg-Positive Chronic Hepatitis B (CHB)
• A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Volunteers Who Receive Long-Term Prophylaxis Against Pandemic Influenza: PIPET B
• Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia
• Study To Assess The Impact Of Hepatic Impairment On The Safety, Tolerability And Pharmacokinetics Of Single-Dose 200 Mg Of PF-868554
• Chronic Hepatitis B Antihepadnaviral Resistance Mutation (CHARM) Study
• Immunogenicity of GSK Biologicals Pandemic Influenza Vaccine (GSK1562902A) at Different Vaccination Schedules
• Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-Infected Patients (SWAP)
• A Phase I, Randomized, Single-Blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18- 40 Years of Age
• Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin (RelapC)
• Exercise and Pioglitazone for HIV-Metabolic Syndromes
• Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections
• Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV co-Infection in Vietnam
• Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired Pneumonia
• Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria Vaccine
• GSK1247303 First Time in Human Study
• A Multi-Center Study to Compare Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster in Immunocompetent Patients 18 Years or Older
• Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine (EBEREST)
• Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama
• Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity Study in VLBW Neonates of BSYX-A110 for Prevention of Staphylococcal Infection (N007)
• Microdialysis and Pharmacokinetic Study of TR-701
• A Multiple Ascending Dose Study of BMS-790052 in Hepatitis C Virus (HCV) Infected Subjects
• Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-Infected Men
• CS-8958 Single Inhaled Dose in Elderly
• Pilot Study Examining the Safety and Tolerability of Low Dose Linezolid in the Treatment of Multi-Drug Resistant Tuberculosis (LiMiT)
• High-Dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4 (VIRID)
• A Single Ascending Dose Study of BMS-791325 in HCV Infected Subjects
• Safety and Antiviral Activity of Etravirine (TMC125) in Treatment-Experienced, HIV Infected Children and Adolescents
• Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals HBV Vaccine
• Comparison of GSK134612 in Subjects Previously Vaccinated Against Meningococcal Disease Versus Non-Vaccinated Subjects